Journal of the Korean Medical Association (대한의사협회지)

Korean Medical Association (대한의사협회)
권호 표지
DOI QR코드

DOI QR Code

Pharmacokinetics and pharmacodynamics of drugs for sedation

진정요법에 쓰이는 약물들의 약동학과 약력학

Lee, Yoon Sook
이윤숙

  • Published : 20130400
⟨ Previous Next ⟩

Abstract

Pharmacokinetics describes the processes of absorption, distribution, and elimination of drugs and pharmacodynamics describes the effect of drugs on the body. Sedation can be performed by various classes of drugs each with its own mechanism of action and using varying routes of administration: oral, rectal, or parenteral. The course of sedation over time is a reflection of the relationship between pharmacokinetics and pharmacodynamics. The safety and efficacy of sedation is mainly dependant on understanding pharmacologic principles. This review will focus on the general concepts of the pharmacokinetics and pharmacodynamics of drugs used for sedation.

Keywords

References

  1. American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology 2002;96:1004-1017. https://doi.org/10.1097/00000542-200204000-00031
  2. Grandison MK, Boudinot FD. Age-related changes in protein binding of drugs: implications for therapy. Clin Pharmacokinet 2000;38:271-290 https://doi.org/10.2165/00003088-200038030-00005
  3. Hughes MA, Glass PS, Jacobs JR. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 1992;76:334-341 https://doi.org/10.1097/00000542-199203000-00003
  4. Wright SW, Chudnofsky CR, Dronen SC, Kothari R, Birrer P, Blanton DM, Bruner A. Comparison of midazolam and diazepam for conscious sedation in the emergency department. Ann Emerg Med 1993;22:201-205 https://doi.org/10.1016/S0196-0644(05)80203-3
  5. Greenblatt DJ, Abernethy DR, Locniskar A, Harmatz JS, Limjuco RA, Shader RI. Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology 1984;61:27-35
  6. Boswinkel JP, Litman RS. Sedating patients for radiologic studies. Pediatr Ann 2005;34:650-654 https://doi.org/10.3928/0090-4481-20050801-13
  7. Shibutani K, Inchiosa MA, Sawada K, Bairamian M. Pharmacokinetic mass of fentanyl for postoperative analgesia in lean and obese patients. Br J Anaesth 2005;95:377-383 https://doi.org/10.1093/bja/aei195
  8. Vaughn RL, Bennett CR. Fentanyl chest wall rigidity syndrome: a case report. Anesth Prog 1981;28:50-51
  9. Dershwitz M, Hoke JF, Rosow CE, Michalowski P, Connors PM, Muir KT, Dienstag JL. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology 1996;84:812-820 https://doi.org/10.1097/00000542-199604000-00008
  10. Hoke JF, Shlugman D, Dershwitz M, Michalowski P, Malthouse-Dufore S, Connors PM, Martel D, Rosow CE, Muir KT, Rubin N, Glass PS. Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers. Anesthesiology 1997;87:533-541 https://doi.org/10.1097/00000542-199709000-00012
  11. Egan TD, Huizinga B, Gupta SK, Jaarsma RL, Sperry RJ, Yee JB, Muir KT. Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology 1998;89:562-573 https://doi.org/10.1097/00000542-199809000-00004
  12. Barr J, Egan TD, Sandoval NF, Zomorodi K, Cohane C, Gambus PL, Shafer SL. Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model. Anesthesiology 2001;95:324-333 https://doi.org/10.1097/00000542-200108000-00011
  13. Shafer SL. Advances in propofol pharmacokinetics and pharmacodynamics. J Clin Anesth 1993;5:14S-21S https://doi.org/10.1016/0952-8180(93)90003-W
  14. Veselis RA, Reinsel RA, Feshchenko VA, Wronski M. The comparative amnestic effects of midazolam, propofol, thiopental, and fentanyl at equisedative concentrations. Anesthesiology 1997;87:749-764 https://doi.org/10.1097/00000542-199710000-00007
  15. White PF, Way WL, Trevor AJ. Ketamine: its pharmacology and therapeutic uses. Anesthesiology 1982;56:119-136 https://doi.org/10.1097/00000542-198202000-00007
  16. Okamoto GU, Duperon DF, Jedrychowski JR. Clinical evaluation of the effects of ketamine sedation on pediatric dental patients. J Clin Pediatr Dent 1992;16:253-257
  17. Venn RM, Karol MD, Grounds RM. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive caret. Br J Anaesth 2002;88:669-675 https://doi.org/10.1093/bja/88.5.669
  18. Tan JA, Ho KM. Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis. Intensive Care Med 2010;36:926-939 https://doi.org/10.1007/s00134-010-1877-6
  19. Maze M, Scarfini C, Cavaliere F. New agents for sedation in the intensive care unit. Crit Care Clin 2001;17:881-897 https://doi.org/10.1016/S0749-0704(05)70185-8

Cited by

  1. Criminal liability of medical professionals vol.56, pp.8, 2013, https://doi.org/10.5124/jkma.2013.56.8.655
  2. Propofol abuse among healthcare professionals vol.56, pp.9, 2013, https://doi.org/10.5124/jkma.2013.56.9.771
  3. 최근 5년간 연세대학교 치과대학병원 소아치과의 환자 분포 및 치료 경향 vol.41, pp.2, 2013, https://doi.org/10.5933/jkapd.2014.41.2.134
  4. 소아치과의사의 진정법 사용에 대한 실태조사 vol.41, pp.3, 2013, https://doi.org/10.5933/jkapd.2014.41.3.257